Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-10 production during septicaemia

A Marchant1, J Devière, B Byl

  • 1Department of Immunology, Hôpital Erasme, Université Libre de Bruxelles, Belgium.

Lancet (London, England)
|March 19, 1994
PubMed
Summary

Interleukin-10 (IL-10) is produced during sepsis and helps control the inflammatory response. This cytokine down-regulates tumor necrosis factor-alpha production, suggesting a role in managing endotoxemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of published guidance on trends in the pharmacological management of depression in children and adolescents- a whole population e-cohort data linkage study in Wales, UK.

Psychological medicine·2025
Same author

Accuracy and other quality indicators of solid pancreatic mass endoscopic ultrasound-guided fine needle aspiration and biopsy in two academic endoscopy centers.

Acta gastro-enterologica Belgica·2021
Same author

Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.

Journal of internal medicine·2021
Same author

The Belgian national registry on chronic pancreatitis: A prospective multi-centre study covering more than 800 patients in one year.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2017
Same author

Pan-genome multilocus sequence typing and outbreak-specific reference-based single nucleotide polymorphism analysis to resolve two concurrent Staphylococcus aureus outbreaks in neonatal services.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practice.

Antimicrobial resistance and infection control·2015

Area of Science:

  • Immunology
  • Infectious Diseases
  • Biochemistry

Background:

  • Bacterial lipopolysaccharide (LPS) triggers inflammatory responses, including tumor necrosis factor-alpha (TNF-α) production.
  • Interleukin-10 (IL-10) is a cytokine known to possess immunosuppressive properties.
  • Understanding cytokine dynamics during sepsis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the production of IL-10 in human whole blood stimulated with LPS in an in-vitro model of endotoxemia.
  • To measure plasma IL-10 levels in patients with gram-negative and gram-positive septicemia and compare them to healthy controls.
  • To assess the correlation between IL-10 levels and the severity of sepsis, specifically septic shock.

Main Methods:

  • Incubation of human whole blood with bacterial lipopolysaccharide (LPS).

Related Experiment Videos

  • Quantification of plasma Interleukin-10 (IL-10) levels using [assay not specified].
  • Comparison of IL-10 levels between septic patients (with and without shock) and healthy volunteers.
  • Main Results:

    • IL-10 was produced in vitro upon LPS stimulation, down-regulating TNF-α production.
    • Elevated plasma IL-10 levels were detected in 57% of septic patients (gram-negative and gram-positive).
    • Septic shock patients exhibited significantly higher IL-10 levels (mean 58 pg/mL) compared to non-shock septic patients (mean 11 pg/mL, p < 0.001).
    • IL-10 was undetectable in most control patients and healthy volunteers.

    Conclusions:

    • Interleukin-10 is actively produced during human sepsis.
    • IL-10 may play a role in modulating the host's inflammatory response to bacterial products.
    • IL-10 levels correlate with sepsis severity, indicating potential as a biomarker.